期刊
BRITISH JOURNAL OF HAEMATOLOGY
卷 165, 期 5, 页码 659-672出版社
WILEY-BLACKWELL
DOI: 10.1111/bjh.12815
关键词
chronic lymphocytic leukaemia; Lyn; nocodazole; inhibitor; apoptosis
类别
资金
- Ministero dell'Istruzione dell'Universita e della Ricerca
- AIRC Regional Project
- Fondazione CARIPARO
- CARIVERONA
- Regione Veneto on Chronic Lymphocytic Leukaemia
- University of Padova, Italy
Functional abnormalities of chronic lymphocytic leukaemia (CLL) cells may be related to the microtubular network of cell cytoskeleton; specifically tubulin involvement in cells after B-cell receptor engagement. As microtubule inhibitors could represent a therapeutic strategy for CLL, this study investigated the capability of nocodazole, a synthetic depolymerizing agent, to kill CLL leukaemic cells. We demonstrated that nocodazole was highly specific for the in vitro induction of apoptosis in leukaemic cells from 90 CLL patients, without affecting the viability of T-cells and/or mesenchymal stromal cells (MSCs) recovered from the same patients. Nocodazole was observed to overcome the pro-survival signals provided by MSCs. Competing with ATP for the nucleotide-binding site, nocodazole has been observed to turn off the high basal tyrosine phosphorylation of leukaemic cells mediated by the Src-kinase Lyn. Considering that most anti-microtubule drugs have limited clinical use because of their strong toxic effects, the high selectivity of nocodazole for leukaemic cells in CLL and its capability to bypass microenvironmental pro-survival stimuli, suggests the use of this inhibitor for designing new therapeutic strategies in CLL treatment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据